Please try another search
4D Molecular Therapeutics, Inc., a clinical-stage biotherapeutics company, develops genetic medicines using its therapeutic vector evolution platform in the Netherland and the United States. The company develops a portfolio of genetic medicine product candidates focuses in three therapeutic areas for ophthalmology, cardiology, and pulmonology. Its product pipeline includes 4D-150, which is in phase 1/2 clinical trial for the treatment of wet age-related macular degeneration; and is in phase 1/2 clinical trial for the treatment of diabetic macular edema. The company develops 4D-125, which is in phase 1/2 clinical trial for the treatment of x-linked retinitis pigmentosa; 4D-110, which is in phase 1/2 clinical trial for the treatment of choroideremia; 4D-710, which is in phase 1/2 clinical trial for the treatment cystic fibrosis lung disease; and 4D-310 to treat fabry disease cardiomyopathy and is in phase 1/2 clinical trial. In addition, its product candidates comprises 4D-175, which is in pre-clinical development for the treatment for geographic trophy; and 4D-725 to treat alpha-1 antitrypsin deficiency lung disease and is in pre-clinical development. The company has collaboration and licensing agreements with Arbor Biotechnologies, Inc.; Astellas Gene Therapies, Inc; uniQure biopharma B.V.; and Cystic Fibrosis Foundation. 4D Molecular Therapeutics, Inc. was founded in 2013 and is headquartered in Emeryville, California.
Name | Age | Since | Title |
---|---|---|---|
John F. Milligan | 60 | 2020 | Executive Chairman |
Nancy Miller-Rich | 63 | 2020 | Independent Director |
Jacob M. Chacko | 43 | 2019 | Independent Director |
David H. Kirn | 60 | 2013 | Co-Founder, CEO & Director |
Daniel F. Takefman | 56 | 2023 | Member of Scientific Advisory Board |
Paul J. Utz | - | 2023 | Member of Scientific Advisory Board |
Amy Rosenberg | - | 2023 | Member of Scientific Advisory Board |
Ronal Crystal | - | 2023 | Member of Scientific Advisory Board |
Amit Gaggar | - | 2023 | Member of Scientific Advisory Board |
Richard B. Moss | - | 2023 | Member of Scientific Advisory Board |
Ramesh Shivdasani | - | - | Member of the Scientific Advisory Board |
Ronald G. Crystal | - | - | Member of the Scientific Advisory Board |
Douglas Hanahan | - | - | Member of the Scientific Advisory Board |
Charles P. Theuer | 60 | 2015 | Independent Director |
Shawn Cline Tomasello | 65 | 2020 | Independent Director |
Susannah Gray | 63 | 2020 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review